Notice of AGM

By

Regulatory News | 17 May, 2022

Updated : 07:00

RNS Number : 6811L
RTW Venture Fund Limited
17 May 2022
 

LEI: 549300Q7EXQQH6KF7Z84

17 May 2022

RTW Venture Fund Limited

Notice of Annual General Meeting

RTW Venture Fund Limited (the "Company") announces that its Annual General Meeting ("AGM") will be held at 1st Floor Royal Chambers, St Julian's Avenue St Peter Port, Guernsey on 21 June 2022 at 2pm BST. The Notice of AGM will shortly be dispatched to all shareholders.

A copy of the Notice of AGM has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism The Notice of AGM may also be viewed on the Company's website at https://www.rtwfunds.com/venture-fund/.

The Annual Report and Audited Financial Statements for the year ended 31 December 2021 (the "Annual Report") is also available on the Company's website https://www.rtwfunds.com/venture-fund/ at  and on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

The Board anticipates that at the time of the Annual General Meeting Shareholders will be able to attend the meeting in person, subject to any COVID-19 restrictions that might be imposed by the States of Guernsey. You will not have received a hard copy proxy form for the AGM in the post. You can instead submit your proxy vote electronically by accessing the shareholder portal at www.signalshares.com, logging in and selecting the 'Vote Online Now' link. Full details of how to vote are set out in the Notes to the Notice of Meeting. Please submit your proxy vote so as to reach the Company's registrar as soon as possible and in any event no later than 2pm BST on 17 June 2022 or, if you are a CREST member, by using the service provided by Euroclear. The completion of the form of proxy will not preclude a member from attending and voting in person at the meeting if it is so allowed.

If any shareholder has questions related to the business of the AGM, please submit your queries at https://www.rtwfunds.com/venture-fund/ by 2pm BST on 17 June 2022. We will endeavour to answer every shareholder question and responses will be posted on the Company's website after the AGM.

For Further Information

RTW Investments, LP                                        +1 (646) 597 6980
Stephanie Sirota, Chief Business Officer

Woody Stileman, Managing Director

 

Elysium Fund Management Limited              +44 (0) 14 8181 0100

Joanna Duquemin Nicolle, Chief Executive Officer

Sadie Morrison, Managing Director

 

J.P. Morgan Cazenove                                       +44 (0)20 7742 4000

William Simmonds

Jérémie Birnbaum

James Bouverat (Sales)

 

BofA Securities                                                 +44 (0) 20 7628 1000

Edward Peel

Kieran Millar

 

 

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund Limited invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOASFIFMMEESEDI

Last news